Preventing and managing antimicrobial resistance: imperative for chest physicians
- 30 April 2011
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 37 (5) , 978-981
Abstract
The identification of AMR as a serious international health issue comes at a crucial point in the global attempt to contain its impact. Strategies have been defined by WHO in the past decade, but rarely implemented 3. In the past few years, the appearance of multidrug-resistant organisms capable of resisting the most potent latest-generation antibiotics and chemotherapeutic agents has generated substantial apprehension among clinicians and public health experts (fig. 1).Keywords
This publication has 24 references indexed in Scilit:
- The WHO policy package to combat antimicrobial resistanceBulletin of the World Health Organization, 2011
- NDM-1 — A Cause for Worldwide ConcernNew England Journal of Medicine, 2010
- Containing antimicrobial resistance: a renewed effortBulletin of the World Health Organization, 2010
- MDR Tuberculosis — Critical Steps for Prevention and ControlNew England Journal of Medicine, 2010
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Duration of antibiotic therapy in hospitalised patients with community-acquired pneumoniaEuropean Respiratory Journal, 2009
- Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research AgendaPLOS Medicine, 2008
- Introduction: the challenge of multiresistanceInternational Journal of Antimicrobial Agents, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Improving the TB case management: the International Standards for Tuberculosis care: Table 1—European Respiratory Journal, 2006